Hyper-IgM Syndrome
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases (NCT01963143) | Bio Products Laboratory | 2014-02-01 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NCT01652092) | Masonic Cancer Center, University of Minnesota | 2012-09-04 |
| A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency (NCT01289847) | Bio Products Laboratory | 2011-03-01 |
| Studies of Disorders in Antibody Production and Related Primary Immunodeficiency States (NCT00266513) | National Institute of Allergy and Infectious Diseases (NIAID) | 2005-12-14 |
Track Hyper-IgM Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.